JP2010515682A5 - - Google Patents

Download PDF

Info

Publication number
JP2010515682A5
JP2010515682A5 JP2009544925A JP2009544925A JP2010515682A5 JP 2010515682 A5 JP2010515682 A5 JP 2010515682A5 JP 2009544925 A JP2009544925 A JP 2009544925A JP 2009544925 A JP2009544925 A JP 2009544925A JP 2010515682 A5 JP2010515682 A5 JP 2010515682A5
Authority
JP
Japan
Prior art keywords
zileuton
daily dose
administered
pharmaceutical composition
per day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009544925A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010515682A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/000101 external-priority patent/WO2008085875A2/en
Publication of JP2010515682A publication Critical patent/JP2010515682A/ja
Publication of JP2010515682A5 publication Critical patent/JP2010515682A5/ja
Pending legal-status Critical Current

Links

JP2009544925A 2007-01-05 2008-01-04 喘息などの5−リポキシゲナーゼ活性上昇および/またはロイコトリエン活性上昇に関連する状態における使用のためのr−ジロートン Pending JP2010515682A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87927307P 2007-01-05 2007-01-05
PCT/US2008/000101 WO2008085875A2 (en) 2007-01-05 2008-01-04 R-zileuton for use in conditions associated with increased 5-lipoxygenase and/or leukotriene activity (eg asthma)

Publications (2)

Publication Number Publication Date
JP2010515682A JP2010515682A (ja) 2010-05-13
JP2010515682A5 true JP2010515682A5 (https=) 2011-03-03

Family

ID=39339861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009544925A Pending JP2010515682A (ja) 2007-01-05 2008-01-04 喘息などの5−リポキシゲナーゼ活性上昇および/またはロイコトリエン活性上昇に関連する状態における使用のためのr−ジロートン

Country Status (7)

Country Link
US (1) US20100273868A1 (https=)
EP (1) EP2114399A2 (https=)
JP (1) JP2010515682A (https=)
CN (1) CN101674823A (https=)
CA (1) CA2674492A1 (https=)
MX (1) MX2009007247A (https=)
WO (1) WO2008085875A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011049979A2 (en) * 2009-10-19 2011-04-28 Amira Pharmaceuticals, Inc. Injectable formulations for intra- articular or peri-articular administration
CN101829075B (zh) * 2010-04-27 2011-07-20 中国人民解放军第三军医大学第一附属医院 苦柯胺a和苦柯胺b的用途
EP2563359A1 (en) 2010-04-30 2013-03-06 Allergan, Inc. Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase
CN102274213A (zh) * 2010-06-10 2011-12-14 北京润德康医药技术有限公司 含有r(+)-齐留通的药用组合物
EP2959899B1 (en) * 2011-08-23 2017-02-22 Cornerstone Therapeutics Inc. Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients
GB201118193D0 (en) * 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to oranic compounds
GB201118198D0 (en) * 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to organic compounds
CN102429872B (zh) * 2011-11-25 2013-07-10 舒泰神(北京)生物制药股份有限公司 含齐留通的膜控型缓释微丸及其制备方法
WO2016062279A1 (zh) * 2014-10-24 2016-04-28 朗齐生物医学股份有限公司 苹果酸丙氯陪拉辛锭用于制备治疗癌症药物的用途
CN107847468A (zh) * 2015-05-26 2018-03-27 纪念斯隆·凯特琳癌症中心 铁死亡和谷氨酰胺分解抑制剂及其治疗方法
JP2023553290A (ja) * 2020-12-01 2023-12-21 リバースパ エルエルシー 慢性閉塞性肺疾患、喘息、肺炎、気管支炎、嚢胞性線維症、肺水腫、間質性肺疾患、サルコイドーシス、特発性肺胞線維症、急性呼吸窮迫症候群、および肺動脈性肺高血圧症を治療するための方法および組成物
US20260053774A1 (en) * 2022-08-23 2026-02-26 University Of Houston System Parenteral compositions of zileuton and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0697868A4 (en) * 1993-05-10 1998-04-08 Sepracor Inc THERAPIES AND COMPOSITIONS USING OPTICALLY PURE (+) - ZILEUTON
AU2007217770B2 (en) * 2006-02-21 2011-09-08 Cornerstone Therapeutics Inc. New crystal forms and pharmaceutical compositions of (+) -R-zileuton

Similar Documents

Publication Publication Date Title
JP2010515682A5 (https=)
RU2685730C1 (ru) Составы соединений азаиндола
RU2700415C1 (ru) Ингибиторы репликации вирусов гриппа
JP2014528474A5 (https=)
JP2013537891A5 (https=)
JP2010518122A5 (https=)
JP2014506321A5 (https=)
JP2010515715A5 (https=)
JP2013536825A5 (https=)
JP2013526482A5 (https=)
JP2020193206A5 (https=)
HRP20171511T1 (hr) Ivabradin-hidroklorid, oblik iv
JP2013509411A5 (https=)
JP2013518914A5 (https=)
JP2008533127A5 (https=)
JP2010500284A5 (https=)
JP2011157375A5 (https=)
CN105693805A (zh) 一种胆酸类小檗碱偶合物的制备及医药用途
JP2007500176A5 (https=)
US9084807B2 (en) Composition comprising ligustroflavone, rhoifolin and hyperin and its pharmaceutical application
CN1988910A (zh) 含有血小板凝集抑制剂和贝特类化合物的药物组合
JP2013518061A5 (https=)
CN104095858A (zh) 闭花木酮Cleistanone的O-(哌啶基)乙基衍生物在制备抗慢性阻塞性肺病药物中的应用
JP2010527354A5 (https=)
CN102641240B (zh) 一种苦柯胺b盐注射剂及其制备方法